{
    "2021-04-30": [
        [
            {
                "time": "",
                "original_text": "直击欧普康视股东大会，董事长陶悦群：OK镜渗透率较低因终端缺乏技术人员、使用成本高",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "OK镜",
                        "渗透率",
                        "技术人员认证",
                        "使用成本"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "欧普康视OK镜角膜点染率较高？董事长陶悦群：点染率与厚度、验配技术有关系",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "OK镜",
                        "角膜点染率",
                        "产品安全性"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "太平洋证券：欧普康视收入快速恢复增长，净利率稳步提升",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "收入增长",
                        "净利率提升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药“小阳春”行情渐入佳境，医药龙头股票有哪些？",
                "features": {
                    "keywords": [
                        "医药",
                        "小阳春",
                        "龙头股票"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗器械板块持续造好，万泰生物、欧普康视强势领涨，医疗器械ETF（159883）早盘大涨2.35%",
                "features": {
                    "keywords": [
                        "医疗器械",
                        "万泰生物",
                        "欧普康视",
                        "ETF",
                        "领涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "器械"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "太平洋证券维持欧普康视买入评级：收入快速恢复增长，净利率稳步提升",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "买入评级",
                        "收入增长",
                        "净利率提升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "科技和消费板块炙手可热，机构解码“擒牛术”",
                "features": {
                    "keywords": [
                        "科技",
                        "消费",
                        "板块热度",
                        "擒牛术"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "消费"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}